Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
EPKINLY® (epcoritamab) Approved by Japan Ministry of Health, Labour and Welfare for Additional Indication as a Treatment for Relapsed or Refractory Follicular Lymphoma
-
Natural gas remains the crucial bridge in the energy transition, yet challenges persist
-
Sol Strategies Selected as Staking Provider for Tetra Trust's Digital Asset Platform
-
Sabre's fourth quarter and full year 2024 earnings materials available on its Investor Relations website
-
Unity Reports Fourth Quarter and Fiscal Year 2024 Financial Results
-
Two former pet tigers celebrate their February anniversaries at Texas sanctuary
-
Custodian of Two Holy Mosques Approves Saudi Riyal Symbol
-
Polaris Renewable Energy Announces Q4 And Annual 2024 Results
-
JETOUR T1: Lite off-road SUV Pioneer Taking the Global Market by Storm
-
Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of Directors
-
Amarc To Showcase the "AuRORA" High Grade Cu-Au-Ag Discovery at PDAC
-
Galloper Announces Continuation of Private Placement
-
AMSTED Industries Incorporated Announces Tender Offer for Any and All of Its 5.625% Senior Notes Due 2027
-
Introducing Protelion: Your Trusted Cybersecurity Partner
-
Global Times: China's key symposium on private economy boosts confidence
-
Interim Management Report covering H1 2024/25
-
ParaZero Unlocks Growth Opportunities After Achieving European Regulatory Compliance for its SafeAir Systems
-
Grow Therapy Launches AI-assisted Clinical Tools to Enhance Client and Provider Experience
-
Sanu Gold Rapidly Launches Drilling Programme on Its Daina Permit to Follow-up on High-Grade Intercepts Recently Published
-
Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favo
-
Aspire Biopharma Holdings, Inc., Announces Public Listing on Nasdaq
-
Aehr Test Systems to Participate in the 10th Annual Oppenheimer Emerging Growth Conference on February 26, 2025
-
First High-School Education Group Sets Record Date for Dissemination of Transaction Statement and Plan of Merger for Going Private Transaction
-
Troy Minerals Strategically Expands Its Lake Owen Project in Wyoming by 100%
-
Orogen Royalties Announces 34% Increase in Gold Resources at the Merlin Deposit
-
Eskay Mining 2025 Prospecting and Mapping Program Geared to Advance Two High-Value Targets to Drill Readiness
-
AirIQ Announces December 31, 2024 Quarterly Results; Company Reports Double-Digit Growth in Recurring Revenue
-
Premium Resources Closes Book and Upsizes Non-Brokered Private Placement to C$44MM Due to Strong Demand
-
The Shyft Group Reports Fourth Quarter and Full-Year 2024 Results
-
Gold-Rich Cobalt-Copper Mineralization at CAS Property Strengthens Electra’s Idaho Exploration Strategy
-
Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
FTI Consulting Reports Fourth Quarter and Full Year 2024 Financial Results
-
Repligen Reports Fourth Quarter and Full Year 2024 Financial Results
-
Labrador Gold Announces 2025 Exploration Programs for the 100% Owned Hopedale and Borden Lake Gold Projects
-
Mandalay Resources Reports 2024 Mineral Reserves and Resources Approaching Two Million Gold Equivalent Ounces in Measured and Indicated Resources
-
Global Crossing Airlines Sets Fourth Quarter and Full Year 2024 Conference Call for March 6, 2025 at 8:30 a.m. ET
-
Rekor Systems to Announce 2024 Results
-
Western Upper Peninsula Communities Demonstrate Continued Support for the Copperwood Mine Project
-
VR Resources Completes Drilling at Silverback Copper-Gold Project in Northwest Ontario
-
Dun & Bradstreet Reports Fourth Quarter and Full Year 2024 Financial Results
-
Plus Therapeutics Appoints Dr. Michael Rosol as Chief Development Officer
-
BT Group Advances Enterprise Service Innovation by Enabling Future-Proven Business Services With Optiva Platform
-
Purpose Investments Expands Yield Shares Lineup with Seven New ETFs, Offering Enhanced Income Opportunities
-
Southern Company reports fourth-quarter and full-year 2024 earnings
-
Alight Reports Fourth Quarter and Full Year 2024 Results
-
HNI Corporation Reports Fourth Quarter and Fiscal Year 2024 Results
-
NowVertical Completes Debt-to-Equity Conversions
-
Altimmune to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on February 27, 2025
-
Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences
-
Cheniere Reports Fourth Quarter and Full Year 2024 Results and Introduces Full Year 2025 Financial Guidance
